Nevro Corp (NYSE: NVRO) on Monday, soared 4.72% from the previous trading day, before settling in for the closing price of $5.08. Within the past 52 weeks, NVRO’s price has moved between $4.38 and $22.64.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.01%. The company achieved an average annual earnings per share of -6.17%. With a float of $35.17 million, this company’s outstanding shares have now reached $36.36 million.
Let’s determine the extent of company efficiency that accounts for 1215 employees. In terms of profitability, gross margin is 65.58%, operating margin of -22.03%, and the pretax margin is -19.54%.
Nevro Corp (NVRO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Nevro Corp is 5.67%, while institutional ownership is 100.30%.
Nevro Corp (NVRO) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.65 earnings per share (EPS) for the period topping the consensus outlook (set at -0.77) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.17% per share during the next fiscal year.
Nevro Corp (NYSE: NVRO) Trading Performance Indicators
Nevro Corp (NVRO) is currently performing well based on its current performance indicators. A quick ratio of 3.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.12, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -2.61 in one year’s time.
Technical Analysis of Nevro Corp (NVRO)
Looking closely at Nevro Corp (NYSE: NVRO), its last 5-days average volume was 0.81 million, which is a jump from its year-to-date volume of 0.55 million. As of the previous 9 days, the stock’s Stochastic %D was 33.98%. Additionally, its Average True Range was 0.39.
During the past 100 days, Nevro Corp’s (NVRO) raw stochastic average was set at 15.66%, which indicates a significant decrease from 49.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.04% in the past 14 days, which was lower than the 121.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.24, while its 200-day Moving Average is $9.69. However, in the short run, Nevro Corp’s stock first resistance to watch stands at $5.50. Second resistance stands at $5.68. The third major resistance level sits at $6.02. If the price goes on to break the first support level at $4.98, it is likely to go to the next support level at $4.64. Now, if the price goes above the second support level, the third support stands at $4.46.
Nevro Corp (NYSE: NVRO) Key Stats
Market capitalization of the company is 188.69 million based on 37,283K outstanding shares. Right now, sales total 425,170 K and income totals -92,210 K. The company made 104,160 K in profit during its latest quarter, and -19,580 K in sales during its previous quarter.
